Previous Close | 0.0008 |
Open | 0.0008 |
Bid | 0.0006 x 0 |
Ask | 0.0007 x 0 |
Day's Range | 0.0007 - 0.0008 |
52 Week Range | 0.0003 - 0.0018 |
Volume | |
Avg. Volume | 6,894,587 |
Market Cap | 7.267M |
Beta (5Y Monthly) | -0.24 |
PE Ratio (TTM) | 0.07 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
HOUSTON, June 05, 2024 (GLOBE NEWSWIRE) -- Vita Biotech Research has entered into a significant partnership with Cannabis Bioscience International Holdings (OTCMKTS: CBIH), to fund the clinical data collection efforts of CBIH’s rigorous data clinical studies, underscoring Vita Biotech's commitment to supporting cutting-edge research and ensuring the highest standards of clinical data integrity. Through this strategic alliance, Vita Biotech will act as a financial subsidiary and catalyst for CBIH
Houston, Texas--(Newsfile Corp. - June 5, 2024) - Vita Biotech Research has entered into a significant partnership with Cannabis Bioscience International Holdings (OTC Pink: CBIH), to fund the clinical data collection efforts of CBIH's rigorous data clinical studies, underscoring Vita Biotech's commitment to supporting cutting-edge research and ensuring the highest standards of clinical data integrity.Through this strategic alliance, Vita Biotech will act as a financial subsidiary and catalyst f
Houston, Texas--(Newsfile Corp. - May 29, 2024) - Cannabis Bioscience International Holdings (OTC Pink: CBIH) announces the engagement of StoneBridge Advisory (stonebridgema.com) for CBIH's company valuation. The Colorado-based firm specializes in business valuations as well as mergers and acquisitions, boasting over three decades of experience in the industry. They represent businesses for sale, and their expertise lies in in-depth professional valuation reports that are IRS Revenue Ruling 59-6